Gencia Corporation
Records under this name other than patents Gencia Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,929,215 | Field widening lens Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,541,550 | Methods and compositions for delivering polynucleotides Lapsed on the fee record Ended Sep 24, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 24, 2021 | USPTO record |
| US 8,507,277 | Nonviral vectors for delivering polynucleotides Lapsed on the fee record Ended Aug 13, 2021 · USPTO record | Lapsed on the fee record | Ended Aug 13, 2021 | USPTO record |
| US 9,707,244 | Compositions and methods for treating conditions that affect epidermis Lapsed on the fee record Ended Jul 18, 2021 · USPTO record | Lapsed on the fee record | Ended Jul 18, 2021 | USPTO record |
| US 9,434,753 | Modified creatine compounds Lapsed on the fee record Ended Sep 6, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 6, 2020 | USPTO record |
| US 8,133,733 | Nonviral vectors for delivering polynucleotides to target tissues Lapsed on the fee record Ended Mar 13, 2020 · USPTO record | Lapsed on the fee record | Ended Mar 13, 2020 | USPTO record |
| US 8,039,587 | Methods and compositions for delivering polynucleotides Lapsed on the fee record Ended Oct 18, 2019 · USPTO record | Lapsed on the fee record | Ended Oct 18, 2019 | USPTO record |
| US 8,952,133 | Nonviral vectors for delivering polynucleotides to target tissue Lapsed on the fee record Ended Feb 10, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 10, 2019 | USPTO record |
| US 8,927,691 | Transducible Polypeptides For Modifying Metabolism Lapsed on the fee record Ended Jan 6, 2019 · Low confidence | Lapsed on the fee record | Ended Jan 6, 2019 | Low confidence |
| US 8,906,390 | Synthetic lipid rafts and methods of use Lapsed on the fee record Ended Dec 9, 2018 · USPTO record | Lapsed on the fee record | Ended Dec 9, 2018 | USPTO record |